AMP Announces Exclusive Distribution Agreement With Estar Medical


AMP partnered with Estar Medical to distribute PRP products in the US market under the Cellenis® brand name. The agreement represents a significant expansion for both companies in the regenerative medicine sector.
Partnership Announcement
Aaron Esteron, CEO of Estar Medical, stated: "The expansion of the Cellenis® brand into the US and the collaboration with AMP represents a key step forward in our global expansion strategy."
AMP Perspective
Erik Dowell, AMP's CEO, emphasized the partnership's value: "Cellenis® PRP is a global brand known around the world for its quality manufacturing and superior clinical outcomes."
Strategic Value
The arrangement combines Estar Medical's platelet-rich plasma technology with AMP's distribution infrastructure and product portfolio of aesthetic devices and biologics.


